CONTACT US
Continuing Medical Education Opportunities
The Pancreatic Cancer Action Network partners with leading organizations to create continuing medical education opportunities for healthcare professionals.
The Art of Therapeutic Balance: Innovations in Pancreatic Cancer Across the Disease Continuum
Join us in person or online for this interactive symposium held during ASCO 2026 and gain new insights from a panel of experts on the latest in treatment selection and sequencing, toxicity mitigation, and emerging therapies including RAS inhibitors across the continuum of pancreatic cancer care—from resectable to advanced disease.
Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with the Pancreatic Cancer Action Network (PanCAN). Supported by an educational grant from Revolution Medicines, Inc.
In Person: Hilton Chicago, 720 S Michigan Ave, Lower Level, Salon A, Chicago, IL 60625 | 6:30 PM – 8:30 PM CT
Virtual Simulcast: 7:00 PM – 8:30 PM CT
Certified On-Demand webcast available post-event.
Register NowCracking the Code in PDAC: Advancing Biomarker Testing and Precision Care
Gain practical, real-world strategies to improve outcomes in pancreatic ductal adenocarcinoma (PDAC). This expert-led CME program explores early molecular profiling, precision treatment planning, and multidisciplinary care approaches.
This activity is jointly provided by Global Education Group (Global) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC), in collaboration with the Pancreatic Cancer Action Network (PanCAN)
Register Now
Pancreatic Cancer 101: From Diagnosis, Detection to Patient Experience
This module offers a comprehensive overview of pancreatic cancer, starting with what the pancreas does and why early detection can be difficult. It covers common and subtle signs, how symptoms change with different stages, and the main types of pancreatic cancer, along with current stats and trends.
Speakers will also discuss high risk factors and how high-risk patients are monitored, ending with a patient perspective on living with pancreatic cancer and her surveillance experience.
Register Now
Digestive Disease Week (DDW)
May 2-5, 2026 | Chicago, IL
In-Person and Virtual Attendance
Learn MoreASCO Annual Meeting
May 29-June 2, 2026 | Chicago, IL
Learn More
Pancreatic Cancer Conference 2026
July 7-9, 2026 | Park Plaza Victoria London
Learn More
6th RAS Initiative Symposium
October 7-9, 2026 | Frederick, MD
Learn More
CONTINUING EDUCATION COURSES:
Metastatic pancreatic ductal adenocarcinoma (PDAC): from diagnosis to treatment
Risk factors, diagnostic tools and treatment options for different patient groups
Metastatic pancreatic ductal adenocarcinoma (PDAC) | COR2EDChemotherapy strategies for metastatic pancreatic ductal adenocarcinoma
Information on standard first and second-line treatments for pancreatic cancer.
Chemotherapy strategies in metastatic pancreatic cancer | COR2EDTackling metastatic pancreatic ductal adenocarcinoma (mPDAC)
A discussion on treatment options for both first and second-line. Side effects and treating vulnerable populations, the importance of supportive care and maintenance therapy.
Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) | COR2EDThese are continuing education microlearning courses offered through COR2ED on the pancreatic cancer basics, management, and treatment options.
